CFTR and cystic fibrosis: Accordingly, high-throughput sequencing has represented a major breakthrough in CF diagnosis, due to increased information output during CFTR sequencing, enabling quick and efficient genotypic identification (CFTR variant) with full gene screening, when associated with the identification of deletions and insertions, for example, using MLPA (multiplex ligation-dependent probe amplification)12,13.